The trademark application CARDINAL-HF was filed by Cardurion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 7, 2022, and it was registered by office on July 15, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).